Generating a human induced pluripotent stem cell line (XACHi018-A) from a Timothy syndrome infant carrying heterozygous CACNA1C c.1216G>A > A (p.G406R) mutation

被引:0
|
作者
Jiang, Congshan [1 ]
Huang, Wenjun [1 ]
Zhou, Yafei [1 ]
Wang, Jie [1 ]
Lei, Hong [1 ]
Niu, Youguo [3 ]
Zhou, Rui [1 ]
Zhang, Yanmin [1 ,2 ]
机构
[1] Xian Jiaotong Univ Xian, Xian Childrens Hosp,Xian Key Lab Childrens Hlth &, Shaanxi Inst Pediat Dis,Key Lab Precis Med Pediat, Natl Reg Childrens Med Ctr Northwest,Affiliated Ch, 69 Xijuyuan Lane, Xian 710003, Peoples R China
[2] Xi An Jiao Tong Univ, Xian Childrens Hosp, Dept Cardiol, Affiliated Childrens Hosp, Xian, Peoples R China
[3] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England
基金
中国国家自然科学基金;
关键词
D O I
10.1016/j.scr.2024.103513
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Timothy syndrome, an extremely rare disease, is closely associated with a mutation in CACNA1C gene, which encodes the cardiac L-type voltage-gated calcium channel (Cav1.2). In this study, we generated a human induced pluripotent stem cell (iPSC) line from a Timothy syndrome infant carrying heterozygous CACNA1C mutation (transcript variant NM_000719.7c.1216G>A: p.G406R). The generated iPSC line showed typical stem cell morphology, positively expressed pluripotency and proliferation markers, normal karyotype, and trilineage differentiation potential. Therefore, this patient-specific iPSC can be of great significance in investigating the mechanisms underlying Timothy syndrome, and hence establishing effective intervention strategies.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Generation of an induced pluripotent stem cell line (TRNDi030-A) from a patient with Farber disease carrying a homozygous p. Y36C (c. 107 A>G) mutation in ASAH1
    Brooks, Brianna M.
    Yeh, Charles D.
    Beers, Jeanette
    Liu, Chengyu
    Cheng, Yu-Shan
    Gorshkov, Kirill
    Zou, Jizhong
    Zheng, Wei
    Chen, Catherine Z.
    STEM CELL RESEARCH, 2021, 53
  • [22] Generation of the induced pluripotent stem cell(iPSC) line (AHQUi001-A) from a patient with familial hypertriglyceridemia (FHTG) carrying a heterozygous p.C310R (c.928 T > C) mutation in LPL gene
    Sun, Xiaofang
    Zhou, Xiang
    Xiao, Xinhua
    Chi, Jingwei
    Dong, Bingzi
    Wang, Yangang
    STEM CELL RESEARCH, 2020, 45
  • [23] Generation of a human induced pluripotent stem cell (iPSC) line from a patient with family history of diabetes carrying a C18R mutation in the PDX1 gene
    Wang, Xianming
    Chen, Shen
    Burtscher, Ingo
    Sterr, Michael
    Hieronimus, Anja
    Machicao, Fausto
    Staiger, Harald
    Haering, Hans-Ulrich
    Lederer, Gabriele
    Meitinger, Thomas
    Lickert, Heiko
    STEM CELL RESEARCH, 2016, 17 (02) : 292 - 295
  • [24] Generation of a human induced pluripotent stem cell line ZZUNEUi030-A from a female patient carrying a heterozygous CALM2 (c.395 A > T) mutation
    Hua, Chongpei
    Sun, Wenrui
    Zhang, Chunjin
    Tian, Xiaoxu
    Qin, Xintong
    Dong, Jianzeng
    Li, Xiaowei
    STEM CELL RESEARCH, 2024, 81
  • [25] Establishment of a human induced pluripotent stem cell line (SDQLCHi079-A) from a patient with Johanson-Blizzard syndrome carrying heterozygous mutation in UBR1 gene
    Wang, Bin
    Yang, Lu
    Gao, Min
    Zhang, Haiyan
    Ji, Aihua
    Liu, Guohua
    Liu, Yi
    STEM CELL RESEARCH, 2024, 80
  • [26] Generation of an integration-free induced pluripotent stem cell line, FJMAi001-A, from a Marfan syndrome patient with a heterozygous mutation c.2777G > A (p.Cys926Tyr) in FBN1
    Liu, Ronghua
    Weng, Guoxing
    Zheng, Fuzhen
    Chen, Jinyan
    Wang, Kun
    Han, Junyong
    Huang, Jie
    Yan, Licheng
    Jin, Jingjun
    STEM CELL RESEARCH, 2024, 81
  • [27] Human induced pluripotent stem cells derived from a patient with a mutation of SERPINC1 c.236G>A (p.R79H)
    Chen, Weijie
    Wang, Yuanyuan
    Shen, Liwei
    Huang, Shengwen
    Yang, Xiaoli
    Wu, Danhong
    STEM CELL RESEARCH, 2023, 71
  • [28] Generation of an induced pluripotent stem cell line (TRNDi012-B) from Fibrodysplasia Ossificans Progressiva (FOP) patient carrying a heterozygous mutation c. 617G > A in the ACVR1 gene
    Huang, Xiuli
    Roeder, Amanda
    Li, Rong
    Beers, Jeanette
    Liu, Chengyu
    Zou, Jizhong
    Yu, Paul B.
    Zheng, Wei
    STEM CELL RESEARCH, 2021, 54
  • [29] Generation of an induced pluripotent stem cell line (SHCDNi007-A) from a patient with pyruvate carboxylase deficiency carrying compound heterozygous (c.182 T > C/ c.2581G > A) variants in PC
    Sun, Jingjing
    Lu, Pei
    Shen, Yunlin
    Ma, Li
    STEM CELL RESEARCH, 2023, 66
  • [30] Generation of an induced pluripotent stem cell line (ZJULLi003-A) from a hypertrophic cardiomyopathy patient carrying MYH7/c.4384G > A mutation
    Zhou, Jingjun
    Sun, Yaxun
    Wang, Hongkun
    Wang, Hao
    Guo, Fengfeng
    Chen, Xianzhen
    Gong, Tingyu
    Jiang, Chenyang
    Liang, Ping
    STEM CELL RESEARCH, 2022, 64